KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Cardlytics (CDLX) Preferred Stock Liabilities (2016 - 2017)

Cardlytics filings provide 2 years of Preferred Stock Liabilities readings, the most recent being $5.1 million for Q4 2017.

Quarterly Preferred Stock Liabilities fell 84.35% to $5.1 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2017, down 84.35% year-over-year, with the annual reading at $5.1 million for FY2017, 84.35% down from the prior year.
Preferred Stock Liabilities hit $5.1 million in Q4 2017 for Cardlytics, down from $32.6 million in the prior quarter.
Across five years, Preferred Stock Liabilities topped out at $32.6 million in Q4 2016 and bottomed at $5.1 million in Q4 2017.